Physician profile
Bassem M Eldaif
NPI 1881869089
$2,432.43
in general payments reported to CMS, 2019-2025
22 companies · $921 in 2025
The $921 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.21 · 2020: $179 · 2021: $228 · 2022: $395 · 2023: $224 · 2024: $473 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $455.42 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml |
| Axonics, INC. | $317.52 | 2020-2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $313.69 | 2023-2025 | Prolaris, Myrisk |
| Medtronic, INC. | $193.07 | 2024-2025 | Interstim |
| Ferring Pharmaceuticals INC. | $167.57 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $164.89 | 2025 | Carvykti, Rybrevant, Erleada |
| Teleflex LLC | $157.48 | 2022-2025 | Urolift |
| Srs Medical Systems, INC. | $141.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $120.65 | 2025 | |
| Intuitive Surgical, INC. | $72.61 | 2021 | |
| Olympus America INC. | $47.26 | 2023-2024 | Itind System |
| Profound Medical Corp. | $46.99 | 2025 | Tulsa-Pro |
| Valencia Technologies Corporation | $46.76 | 2025 | Ecoin Device Kit |
| Cook Medical LLC | $29.60 | 2025 | Litho 150 |
| Bayer Healthcare Pharmaceuticals INC. | $29.09 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $27.05 | 2025 | |
| Dendreon Pharmaceuticals LLC | $25.95 | 2025 | Provenge |
| Antares Pharma, INC. | $16.42 | 2020 | |
| Verity Pharmaceuticals INC. | $16.30 | 2025 | Trelstar |
| Halozyme INC | $16.24 | 2023 | |
| Pfizer INC. | $14.69 | 2022 | |
| Neotract INC. | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassem Eldaif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.